Skip to main content
JANL logo

JANL · Janel Corp · Financials

Track JANL — free
$49.00 +4.00 (+8.89%) At close · Oct 19
Market Cap
$58.13M
Shares
1.19M
Volume · Oct 19 300 Avg daily vol (3M) 473

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$207.44M +13.2%
FY2025 Revenue FY2009–FY2025
Net Income
$5.66M +926.7%
FY2025 Net Income FY2009–FY2025
Gross Margin
31.33% -0.5pp
FY2025 Gross Margin FY2016–FY2025
Operating Margin
3.1% +1pp
FY2025 Operating Margin FY2009–FY2025
Diluted EPS
$4.17 +2216.7%
FY2025 Diluted EPS FY2012–FY2025
Operating Cash Flow
$43.07M +530.4%
FY2025 Operating Cash Flow FY2009–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
$237.21M $207.44M $183.18M $186.45M $316.86M $146.42M $82.43M $84.35M $67.52M $58.93M $75.34M $74.74M $47.94M $44.74M $49.84M $98.4M $88.43M $71.66M
$161.87M $142.45M $124.8M $130.78M $250.67M $113.99M $58.91M $59.25M $47.21M $40.91M — — — — — — — —
$75.34M $64.99M $58.38M $55.67M $66.2M $32.43M $23.52M $25.11M $20.31M $18.03M $15.8M — — — — — — —
— 31.33% 31.87% 29.86% 20.89% 22.15% 28.53% 29.76% 30.08% 30.59% 20.97% — — — — — — —
$64.6M $55.87M $52.33M $50.98M $54.72M $27.36M $24.29M $22.61M $18.62M $15.16M $13.05M $9.76M $6.65M $6.45M $6.76M $9.63M $7.5M $7.72M
$3.45M $2.69M $2.3M $2.1M $1.98M $1.12M $955K $915K $807K $766K $594.58K $305.54K -$12.44K — — — — —
$683K $645K $551K $508K $484K $371K $274K — — — — — — $19.19K $31.15K $337.71K $213.58K $301.77K
$68.05M $58.56M $54.63M $53.07M $56.7M $28.48M $25.25M $23.53M $19.43M $56.83M $73.18M $73.2M $48.04M $44.93M $49.81M $98.84M $87.29M $71.44M
$7.29M $6.43M $3.76M $2.6M $9.5M $3.95M -$1.72M $1.58M $887K $2.1M $2.16M $1.54M -$97.13K -$188.37K $30.43K -$440.37K $1.14M $226.42K
— 3.1% 2.05% 1.39% 3% 2.7% -2.09% 1.87% 1.31% 3.57% 2.86% 2.06% -0.2% -0.42% 0.06% -0.45% 1.29% 0.32%
$7.97M $7.08M $4.31M $3.11M $9.98M $4.32M -$1.45M — — — — — — -$169.18K $61.58K -$102.67K $1.36M $528.2K
-$192.73K — — — — — — — — — — — — — -$173.21K -$137.02K -$101.42K $224.71K
$1.89M $2.52M -$346K -$76K — — — — — — — — -$144.24K -$125.74K -$95.45K -$132.93K -$96.46K -$1.28M
— — — -$798K -$7.6M $0 — — — — — — — — — — — —
$8.35M $6.88M $1.09M $525K $52K $6.16M -$2.23M $946K $378K $1.37M $1.48M $1.03M -$241.37K -$314.11K -$65.03K -$573.3K $1.05M -$1.05M
$1.44M $1.22M $543K -$198K $2.19M $961K -$505K $330K $130K $493K -$2.1M $150K $22K $17K $1.22M -$228.05K $446.95K -$325.69K
$5.91M $5.66M $551K $723K -$2.14M $5.2M -$1.73M $616K $248K $727K $3.38M $639.72K -$335.19K -$2.16M -$2.68M -$657.7K $382.9K -$1.24M
— 2.73% 0.3% 0.39% -0.67% 3.55% -2.09% 0.73% 0.37% 1.23% 4.49% 0.86% -0.7% -4.82% -5.37% -0.67% 0.43% -1.73%
— — — — — — — — — $108.08K $82.98K $0 — — — — — —
$5.47M $5.03M $223K $439K -$3.13M $4.44M -$2.4M -$297K $1.07M $210K $2.99M $397.85K -$362.46K -$2.17M -$2.69M -$672.7K $367.85K -$1.26M
— — — — — — — — — — — — -$362.46K -$2.17M -$2.68M -$675.39K $370.32K -$197
USD/shares $4.60 $4.24 $0.19 $0.37 -$3.03 $4.73 -$2.75 -$0.35 $1.86 $0.37 $5.89 $0.71 -$0.67 -$0.10 -$0.12 — — —
USD/shares $4.52 $4.17 $0.18 $0.36 -$3.03 $4.48 -$2.75 -$0.35 $1.28 $0.26 $5.40 $0.67 -$0.63 -$0.09 -$0.12 — — —
shares — 1.19M 1.19M 1.19M 1.03M 938.5K 872.12K 851.23K 574.72K 563.95K 573.95K 599.41K 541.56K 21.58M 21.71M 20.88M 18.22M 17.55M
shares — 1.21M 1.21M 1.21M 1.03M 989.5K 872.12K 851.23K 834.49K 810.41K 626K 592.12K 574.26K 23.21M 23.34M 22.73M 20.84M 17.95M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2017–FY2018: $240K in buybacks.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Long-term debt, including current maturities 2026-06-30 USD 8,780,000 10-Q filed 2026-08-07
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of line of credit borrowings
USD 13,929,000
Noncurrent line of credit borrowings
USD 9,668,000
Operating lease liabilities 2026-06-30 USD 7,231,000 10-Q filed 2026-08-07
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 2,229,000
Noncurrent operating lease liabilities
USD 5,002,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
0.14×
Peer median 0.83×
EV/EBIT
4.56×
P/E (TTM)
10.84×

Peer medians compare against the 10 similar-size Integrated Freight & Logistics companies (of 31 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Logistics $183,823,000 $159,958,000 $166,052,000 $295,343,000 $125,863,000 $68,492,000
Trucking $71,821,000 $73,193,000 — — — —
Ocean Import and Export $49,371,000 $40,567,000 — — — —
Custom Brokerage and Other $33,751,000 $19,445,000 — — — —
Air Import and Export $28,880,000 $26,753,000 — — — —
Life Sciences $14,126,000 $13,154,000 $11,059,000 $11,625,000 $11,992,000 $6,618,000
Manufacturing $9,494,000 $10,072,000 $9,338,000 $9,895,000 $8,564,000 $7,319,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Logistics $183,823,000 $159,958,000 $166,052,000 — — —
Life Sciences and Manufacturing $23,620,000 $23,226,000 $20,397,000 — — —
Air Import and Export — — — $48,312,000 $26,970,000 $16,630,000
Custom Brokerage — — — $12,518,000 $14,424,000 $10,274,000
Ocean Import and Export — — — $123,989,000 $61,436,000 $26,740,000
Trucking — — — $95,333,000 $22,198,000 $14,757,000
Product And Service Other — — — $15,191,000 $835,000 $91,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Logistics $10,383,000 $5,400,000 $4,804,000 $12,322,000 $3,068,000 $103,000
Life Sciences $2,463,000 $3,300,000 $2,534,000 $3,271,000 $3,659,000 $566,000
Manufacturing $1,812,000 $2,282,000 $1,897,000 $2,013,000 $1,885,000 $1,485,000

Operating Margin by Segment (%)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Logistics 5.6% 3.4% 2.9% 4.2% 2.4% 0.2%
Life Sciences 17.4% 25.1% 22.9% 28.1% 30.5% 8.6%
Manufacturing 19.1% 22.7% 20.3% 20.3% 22% 20.3%
Key facts CIK 1133062 CUSIP 47077R109 Visit website